Clinical Trials Browser

Phase NA × Has results × fosaprepitant × Clear all

NCT01504711 2021-04-08

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Phase NA Completed

30 enrolled 12 charts

Gastrointestinal

Gastrointestinal Neoplasms

NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Phase NA Completed

47 enrolled 6 charts

Nausea, Neoplasms, Sarcoma, Vomiting